Strengthening International Ties: MANA PHARMA at the Official Visit of Senegal’s President to Spain
On March 25, MANA PHARMA was represented at a high-level institutional event marking the official visit of Bassirou Diomaye Faye to Spain. The visit, held between March 24 and 26, brought together key stakeholders to reinforce diplomatic, economic, and cooperation ties between both countries.
A central moment of the visit was the reception of the Senegalese Head of State by Their Majesties Felipe VI of Spain and Letizia of Spain. This meeting underscored the shared commitment of Spain and Senegal to advancing bilateral relations and fostering initiatives that promote sustainable development and long-term collaboration.
Institutional engagements of this nature play a critical role in strengthening international partnerships. In an increasingly interconnected world, cooperation between countries is essential to effectively address global challenges—particularly in areas such as healthcare access, economic development, and social progress.
For MANA PHARMA, participation in this context reflects a clear strategic vision. Senegal is emerging as one of the most promising markets in Africa, driven by sustained economic growth and a strong demand for initiatives that improve access to healthcare. These conditions create a solid foundation for impactful, long-term projects aligned with the company’s mission.
Expanding responsibly into international markets remains a key priority for MANA PHARMA. The company continues to focus on developing solutions that respond to structural healthcare challenges, particularly in regions where access remains limited. This approach is rooted in a broader commitment to equity, sustainability, and tangible impact.
As highlighted by the company, international collaboration is not only a strategic lever but also a catalyst for meaningful transformation. By fostering partnerships and supporting initiatives with lasting value, MANA PHARMA aims to contribute to improving quality of life and strengthening healthcare systems globally.
Through its presence at this institutional milestone, MANA PHARMA reinforces its role as an active participant in global health cooperation—committed to building a more accessible and equitable future for healthcare worldwide.
